268 related articles for article (PubMed ID: 15911861)
1. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
[No Abstract] [Full Text] [Related]
2. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
Koren G; Finkelstein Y; Matsui D; Berkovich M
J Obstet Gynaecol Can; 2009 Apr; 31(4):348-350. PubMed ID: 19497154
[No Abstract] [Full Text] [Related]
4. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.
Koren G; Boucher N
Can J Clin Pharmacol; 2009; 16(1):e66-7. PubMed ID: 19164848
[TBL] [Abstract][Full Text] [Related]
5. Fetal and neonatal effects of maternal drug treatment for depression.
Belik J
Semin Perinatol; 2008 Oct; 32(5):350-4. PubMed ID: 18929158
[TBL] [Abstract][Full Text] [Related]
6. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
de Moor RA; Mourad L; ter Haar J; Egberts AC
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants during pregnancy: new research on fetal outcomes raises questions.
Thomas SP
Issues Ment Health Nurs; 2005; 26(2):115-6. PubMed ID: 15962918
[No Abstract] [Full Text] [Related]
8. SSRI use during pregnancy.
Tran H; Robb AS
Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019
[TBL] [Abstract][Full Text] [Related]
9. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
11. Using antidepressants during pregnancy.
Zitner D; Bischoff A
CMAJ; 2005 Nov; 173(10):1205; author reply 1205-6. PubMed ID: 16275973
[No Abstract] [Full Text] [Related]
12. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
Nordeng H; Lindemann R; Perminov KV; Reikvam A
Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
15. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
Nordeng H; Spigset O
Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
[TBL] [Abstract][Full Text] [Related]
16. [SSRI during pregnancy and risk of fetal neurotoxicity. Follow precautions and look for other therapeutic alternatives].
Högberg U; Wang M
Lakartidningen; 2005 Jan 17-23; 102(3):113-5. PubMed ID: 15712734
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review.
Fleschler R; Peskin MF
MCN Am J Matern Child Nurs; 2008; 33(6):355-61; quiz 362-3. PubMed ID: 18997570
[TBL] [Abstract][Full Text] [Related]
18. Birth outcomes in pregnant women taking fluoxetine.
Johnson GL
J Fam Pract; 1997 Jan; 44(1):32. PubMed ID: 9010368
[No Abstract] [Full Text] [Related]
19. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
20. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
Stohl H; Kohm AD; Dossett E
J Neonatal Perinatal Med; 2016; 9(1):1-5. PubMed ID: 27002264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
